×
Showing results for synergene/url?q=/search?q=synergene/search%Sca_esv%3Dabe270d53af57e7a+SynerGene+Therapeutics &sca_esv=10624941311519dc sca_upv=1&tbm=shop&source=lnms&ved=1t:200713&ictx=111
Synergene Active Ingredients Private Limited, incorporated in 2006, is a manufacturer and supplier of Active Pharmaceutical Ingredients (APIs) and ...
Missing: url? q search? q= search% Sca_esv% 3Dabe270d53af57e7a+ &sca_esv= 10624941311519dc sca_upv= 1&tbm= shop&source= lnms&ved= 200713&ictx= 111
People also ask
DESCRIPTION (provided by applicant): In this application, the long-term goal is the development of an effective tumor-targeting lipoplex for ...
Missing: q q= Sca_esv% 3Dabe270d53af57e7a+ &sca_esv= 10624941311519dc sca_upv= 1&tbm= shop&source= lnms&ved= 200713&ictx= 111
Feb 8, 2024 · All individual trials at SynerGene Therapeutics, Inc. ; Trials reported. 1 ; Percent reported. 50.0% ; US Govt could have imposed fines of at least.
Missing: url? q search? q= search% Sca_esv% 3Dabe270d53af57e7a+ &sca_esv= 10624941311519dc sca_upv= 1&tbm= shop&source= lnms&ved= 200713&ictx= 111
May 3, 2024 · SGT-53 is under clinical development by SynerGene Therapeutics and currently in Phase II for Metastatic Adenocarcinoma of The Pancreas.
Missing: q q= Sca_esv% 3Dabe270d53af57e7a+ &sca_esv= 10624941311519dc sca_upv= 1&tbm= shop&source= lnms&ved= 200713&ictx=
Ltd., incorporated in 2006, is a manufacturer and supplier of Active Pharmaceutical Ingredients (APIs) and Intermediates for a wide range of therapeutic ...
Missing: url? q search? q= search% Sca_esv% 3Dabe270d53af57e7a+ &sca_esv= 10624941311519dc sca_upv= 1&tbm= shop&source= lnms&ved= 1t: 200713&ictx= 111
Jan 16, 2015 · When expanded it provides a list of search options that will switch the search inputs to match the current selection. Jobs; People; Learning.
Missing: q q= Sca_esv% 3Dabe270d53af57e7a+ &sca_esv= 10624941311519dc sca_upv= 1&tbm= shop&source= lnms&ved= 200713&ictx= 111
Information on valuation, funding, cap tables, investors, and executives for SynerGene Therapeutics. Use the PitchBook Platform to explore the full profile.
Missing: url? q search? q= search% Sca_esv% 3Dabe270d53af57e7a+ &sca_esv= 10624941311519dc sca_upv= 1&tbm= shop&source= lnms&ved= 1t: 200713&ictx= 111
NCT02340117: An overdue trial by SynerGene Therapeutics, Inc. This trial is overdue. It was due to report 3 months, 1 week ago. ... Phase II Study of Combined ...
Missing: url? q search? q= search% Sca_esv% 3Dabe270d53af57e7a+ &sca_esv= 10624941311519dc sca_upv= 1&tbm= shop&source= lnms&ved= 200713&ictx= 111
In order to show you the most relevant results, we have omitted some entries very similar to the 8 already displayed. If you like, you can repeat the search with the omitted results included.